Bisht Manisha, Singh Shruti, Dhasmana D C
Department of Pharmacology, AIIMS Rishikesh, Virbhadra Road, Rishikesh, Uttarakhand 249 201, India.
Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, Uttarakhand 248140, India.
ISRN Pharmacol. 2014 Mar 18;2014:259476. doi: 10.1155/2014/259476. eCollection 2014.
In India, the pharmacovigilance program is still in its infancy. National Pharmacovigilance Program of India was started for facilitating the pharmacovigilance activities. The ADR reporting rate is still below satisfactory in India. This cross-sectional questionnaire based study was carried out in a tertiary care teaching hospital in Uttarakhand, which is a peripheral ADR monitoring centre to assess the level of knowledge, attitude, and the practices of pharmacovigilance among the doctors and to compare it with the group of doctors attending educational CME for improving awareness of pharmacovigilance. The most important revelation of this study was that although adequate knowledge and the right attitude about adverse drug reaction reporting were instigated in the doctors after the educational intervention, the practice was still neglectful in both groups, emphasizing the need to design the strategies to develop adverse drug reaction reporting culture.
在印度，药物警戒计划仍处于起步阶段。印度国家药物警戒计划旨在推动药物警戒活动的开展。在印度，药品不良反应报告率仍不尽人意。这项基于横断面问卷调查的研究在北阿坎德邦的一家三级护理教学医院进行，该医院是一个外周药品不良反应监测中心，旨在评估医生对药物警戒的知识水平、态度和实践情况，并将其与参加教育性继续医学教育以提高药物警戒意识的医生群体进行比较。这项研究最重要的发现是，尽管教育干预后医生对药品不良反应报告有了足够的知识和正确的态度，但两组医生在实践中仍有所忽视，这凸显了制定策略以培养药品不良反应报告文化的必要性。
